EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic ferroptosis‐starvation therapy for bladder cancer based on hyaluronic acid modified metal–organic frameworks

Yu Wang iD, Kunfeng Xie, Wei Chen, Yunze Fang, Qixin Mo, Henghui Zhang, Xinlei Zhao, Dongqing Li, Wanlong Tan, Peng Zhao, Fei Li

Bioengineering & Translational Medicine · 2023-05 · 8 (3)

DOI: 10.1002/btm2.10515 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioengineering & Translational Medicine, online erschienen am 22.03.2023. Verfasst von Yu Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Nanfang Hospital, Southern Medical University Guangzhou Guangdong 510515 People's Republic of China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer (BCa) is one of the most common malignancies of the urinary tract. Metastasis and recurrence of BCa are the leading causes of poor prognosis, and only a few patients can benefit from current first‐line treatments such as chemotherapy and immunotherapy. It is urgent to develop more effective therapeutic method with low side effects. Here, a cascade nanoreactor, ZIF‐8/PdCuAu/GOx@HA (ZPG@H), is proposed for starvation therapy and ferroptosis of BCa. The ZPG@H nanoreactor was constructed by co‐encapsulation of PdCuAu nanoparticles and glucose oxidase into zeolitic imidazolate framework‐8 (ZIF‐8) modified by hyaluronic acid. The vitro results indicated that ZPG@H enhanced intracellular reactive oxygen species levels and reduced mitochondrial depolarization in the tumor microenvironment. Therefore, the integrated advantages of starvation therapy and chemodynamic therapy endow ZPG@H with a perfect ferroptosis inducing ability. This effectiveness, combined with its excellent biocompatibility and biosafety, means that ZPG@H could make a critical contribution to the development of novel BCa treatments.

Schlagwörter

Stichwörter der Autor:innen

bladder cancerferroptosishyaluronic acidmetal–organic frameworkstarvation therapy

Autor:innen und Institutionen

  • Department of Urology Nanfang Hospital, Southern Medical University Guangzhou Guangdong 510515 People's Republic of China.
  • Department of Urology Zigong Fourth People's Hospital Zigong Sichuan People's Republic of China.
  • Guangdong Provincial Key Laboratory of New Drug Screening, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation School of Pharm…

ORCID-Profile: Yu Wang

Zitieren

APA

Wang, Y., Xie, K., Chen, W., Fang, Y., Mo, Q., Zhang, H., Zhao, X., Li, D., Tan, W., Zhao, P., & Li, F. (2023). Synergistic ferroptosis‐starvation therapy for bladder cancer based on hyaluronic acid modified metal–organic frameworks. Bioengineering & Translational Medicine, 8(3). https://doi.org/10.1002/btm2.10515

Vancouver

Wang Y, Xie K, Chen W, Fang Y, Mo Q, Zhang H, et al. Synergistic ferroptosis‐starvation therapy for bladder cancer based on hyaluronic acid modified metal–organic frameworks. Bioengineering & Translational Medicine. 2023;8(3). doi:10.1002/btm2.10515

BibTeX
@article{Wang2023,
  author = {Wang, Yu and Xie, Kunfeng and Chen, Wei and Fang, Yunze and Mo, Qixin and Zhang, Henghui and Zhao, Xinlei and Li, Dongqing and Tan, Wanlong and Zhao, Peng and Li, Fei},
  title = {Synergistic ferroptosis‐starvation therapy for bladder cancer based on hyaluronic acid modified metal–organic frameworks},
  journal = {Bioengineering & Translational Medicine},
  year = {2023},
  volume = {8},
  number = {3},
  doi = {10.1002/btm2.10515}
}
Kostenlos starten →